Abstract:Objectif : L'hémorragie digestive haute (HDH) est une urgence fréquente en hépatogastroentérologie. Le profil épidémiologique des HDH reste mal connu dans notre pays. Le but de notre travail est de décrire le profil épidémio-logique, étiologique et évolutif des HDH et d'analyser les différents facteurs liés à la mortalité. Matériels et méthodes : Il s'agit d'une étude initialement rétrospective [2001][2002][2003][2004] puis prospective [2005][2006][2007][2008], ayant inclus tous les patients adultes qui se son… Show more
“…The majority of the identified studies were cohort studies, of which 22 were prospective, 8 , 10 , 18 – 37 32 were retrospective, 9 , 38 – 68 and two were ambidirectional analyses. 69 , 70 One RCT, 71 one case–control, 72 and three cross-sectional studies 58 , 73 – 75 were also included in the systematic review.…”
Section: Resultsmentioning
confidence: 99%
“…The rate of HI/shock ranged between 1.2% and 68.3% of the eligible studies. The source of bleeding was UGIB in 54 of the included studies, 8 – 10 , 18 – 34 , 36 , 37 , 39 – 45 , 47 – 50 , 52 – 55 , 58 – 60 , 63 – 76 and LGIB in 7. 35 , 38 , 46 , 51 , 57 , 61 , 62 One study detailed a population including both UGIB and LGIB patients.…”
Section: Resultsmentioning
confidence: 99%
“…The rate of HI/shock ranged between 1.2% and 68.3% of the eligible studies. The source of bleeding was UGIB in 54 of the included studies, [8][9][10][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]36,37,[39][40][41][42][43][44][45][47][48][49][50][52][53][54][55][58][59][60][63][64][65][66][67][68][69][70][71][72][73][74]…”
Section: Basic Characteristics Of Included Studiesmentioning
confidence: 99%
“…35,38,46,51,57,61,62 One study detailed a population including both UGIB and LGIB patients. 56 In terms of outcomes, 44 studies reported mortality, [8][9][10]18,[20][21][22][23][24][25][26][27][28][29][30][32][33][34][35][36][37]39,[41][42][43][47][48][49][52][53][54][55]58,[63][64][65][66][68][69][70][71][73][74][75] 27 rebleeding,…”
Section: Basic Characteristics Of Included Studiesmentioning
Background: Acute gastrointestinal bleeding (GIB) is a life-threatening event. Around 20–30% of patients with GIB will develop hemodynamic instability (HI). Objectives: We aimed to quantify HI as a risk factor for the development of relevant end points in acute GIB. Design: A systematic search was conducted in three medical databases in October 2021. Data sources and methods: Studies of GIB patients detailing HI as a risk factor for the investigated outcomes were selected. For the overall results, pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated based on a random-effects model. Subgroups were formed based on the source of bleeding. The Quality of Prognostic Studies tool was used to assess the risk of bias. Results: A total of 62 studies were eligible, and 39 were included in the quantitative synthesis. HI was found to be a risk factor for both in-hospital (OR: 5.48; CI: 3.99–7.52) and 30-day mortality (OR: 3.99; CI: 3.08–5.17) in upper GIB (UGIB). HI was also associated with higher in-hospital (OR: 3.68; CI: 2.24–6.05) and 30-day rebleeding rates (OR: 4.12; 1.83–9.31) among patients with UGIB. The need for surgery was also more frequent in hemodynamically compromised UGIB patients (OR: 3.65; CI: 2.84–4.68). In the case of in-hospital mortality, the risk of bias was high for 1 (4%), medium for 13 (48%), and low for 13 (48%) of the 27 included studies. Conclusion: Hemodynamically compromised patients have increased odds of all relevant untoward end points in GIB. Therefore, to improve the outcomes, adequate emergency care is crucial in HI. Registration: PROSPERO registration number: CRD42021285727.
“…The majority of the identified studies were cohort studies, of which 22 were prospective, 8 , 10 , 18 – 37 32 were retrospective, 9 , 38 – 68 and two were ambidirectional analyses. 69 , 70 One RCT, 71 one case–control, 72 and three cross-sectional studies 58 , 73 – 75 were also included in the systematic review.…”
Section: Resultsmentioning
confidence: 99%
“…The rate of HI/shock ranged between 1.2% and 68.3% of the eligible studies. The source of bleeding was UGIB in 54 of the included studies, 8 – 10 , 18 – 34 , 36 , 37 , 39 – 45 , 47 – 50 , 52 – 55 , 58 – 60 , 63 – 76 and LGIB in 7. 35 , 38 , 46 , 51 , 57 , 61 , 62 One study detailed a population including both UGIB and LGIB patients.…”
Section: Resultsmentioning
confidence: 99%
“…The rate of HI/shock ranged between 1.2% and 68.3% of the eligible studies. The source of bleeding was UGIB in 54 of the included studies, [8][9][10][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]36,37,[39][40][41][42][43][44][45][47][48][49][50][52][53][54][55][58][59][60][63][64][65][66][67][68][69][70][71][72][73][74]…”
Section: Basic Characteristics Of Included Studiesmentioning
confidence: 99%
“…35,38,46,51,57,61,62 One study detailed a population including both UGIB and LGIB patients. 56 In terms of outcomes, 44 studies reported mortality, [8][9][10]18,[20][21][22][23][24][25][26][27][28][29][30][32][33][34][35][36][37]39,[41][42][43][47][48][49][52][53][54][55]58,[63][64][65][66][68][69][70][71][73][74][75] 27 rebleeding,…”
Section: Basic Characteristics Of Included Studiesmentioning
Background: Acute gastrointestinal bleeding (GIB) is a life-threatening event. Around 20–30% of patients with GIB will develop hemodynamic instability (HI). Objectives: We aimed to quantify HI as a risk factor for the development of relevant end points in acute GIB. Design: A systematic search was conducted in three medical databases in October 2021. Data sources and methods: Studies of GIB patients detailing HI as a risk factor for the investigated outcomes were selected. For the overall results, pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated based on a random-effects model. Subgroups were formed based on the source of bleeding. The Quality of Prognostic Studies tool was used to assess the risk of bias. Results: A total of 62 studies were eligible, and 39 were included in the quantitative synthesis. HI was found to be a risk factor for both in-hospital (OR: 5.48; CI: 3.99–7.52) and 30-day mortality (OR: 3.99; CI: 3.08–5.17) in upper GIB (UGIB). HI was also associated with higher in-hospital (OR: 3.68; CI: 2.24–6.05) and 30-day rebleeding rates (OR: 4.12; 1.83–9.31) among patients with UGIB. The need for surgery was also more frequent in hemodynamically compromised UGIB patients (OR: 3.65; CI: 2.84–4.68). In the case of in-hospital mortality, the risk of bias was high for 1 (4%), medium for 13 (48%), and low for 13 (48%) of the 27 included studies. Conclusion: Hemodynamically compromised patients have increased odds of all relevant untoward end points in GIB. Therefore, to improve the outcomes, adequate emergency care is crucial in HI. Registration: PROSPERO registration number: CRD42021285727.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.